European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer.
Metabolic imaging and early response assessment by positron emission tomography (PET) are gaining importance in guiding treatment of localised and metastatic gastrointestinal tumours. During a workshop organised by the European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group the most relevant research questions, methodological aspects and unmet clinical needs in this disease were discussed. Potential future trials were drafted. This paper reviews the lectures and discussions held during this workshop and summarises the action points for the further investigation of metabolic imaging to guide treatment in gastrointestinal tumours.
Lordick
Florian
F
National Centre for Tumour Diseases, Department of Medical Oncology, University of Heidelberg, Im Neuenheimer Feld 350, 69120 Heidelberg, Germany. florian.lordick@med.uni-heidelberg.de
Ruers
Theo
T
Aust
Daniela E
DE
Collette
Laurence
L
Downey
Robert J
RJ
El Hajjam
Mostafa
M
Flamen
Patrick
P
Haustermans
Karen
K
Ilson
David
D
Julié
Catherine
C
Krause
Bernd Joachim
BJ
Newiger
Hartwig
H
Ott
Katja
K
Roth
Arnaud
A
Van Cutsem
Eric
E
Weber
Wolfgang A
WA
Lutz
Manfred P
MP
D002986:Clinical Trials as Topic; D032921:Consensus; D042241:Early Diagnosis; D005060:Europe; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D020360:Neoadjuvant Therapy; D009683:Nuclear Medicine; D049268:Positron-Emission Tomography; D016896:Treatment Outcome